Genmab

Celldex Therapeutics is a biopharmaceutical company that applies its Immunotherapy Platform to treat various diseases. Its immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. Celldex Therapeutics technology platform uses human monoclonal antibodies administered directly to patients to target dendritic cells and macrophages that are key cells in the immune system. Its APC Targeting Technology delivers an antigen that results in more efficient processing than a nontargeted antigen. The company develops various therapeutic human monoclonal antibody products. Its lead programs are for oncology targets. Celldex Therapeutics has two clinical programs under clinical evaluation for the therapy of cancer.

Established in 1988, PeproTech Inc. is one of the leading suppliers of cytokine products in the world. The firm offers a complete line of products, such as immunoregulatory proteins, chemokines, interferons, adipokines, neurotrophins, defensins, polyclonal/biotinylated/ monoclonal antibodies and recombinant proteins. Located in Rocky Hill, N.J., PeproTech Inc. operates through its 5000-square-foot animal-free manufacturing facility. Through its customer-service offices based in the United States, the United Kingdom, France, Germany, Israel, Korea, China, Japan, Brazil, and Mexico, the firm distributes its products worldwide.

Radpharm is a clinical trial technology company based in Princeton, NJ. They offer a range of solutions, including eCOA (electronic clinical outcome assessments), cardiac safety services, medical imaging, respiratory solutions, and trial enablement. With their expertise in artificial intelligence and precision motion, Radpharm aims to enhance data quality, patient privacy, and data collection processes in clinical trials. They specialize in various therapeutic areas such as cardiovascular, metabolic, dermatology, gastroenterology, infectious diseases, musculoskeletal, neuroscience, oncology, ophthalmology, and respiratory solutions. Radpharm is committed to delivering more certain outcomes in virtual or hybrid trials through their precision endpoint technology and services. They also emphasize their scientific expertise, security governance, and strategic partnerships to support their clients' clinical trial needs.Generated from the website